WO2000058264A1 - Method for the synthesis of non-symmetrical dtpa compounds - Google Patents

Method for the synthesis of non-symmetrical dtpa compounds Download PDF

Info

Publication number
WO2000058264A1
WO2000058264A1 PCT/US2000/007461 US0007461W WO0058264A1 WO 2000058264 A1 WO2000058264 A1 WO 2000058264A1 US 0007461 W US0007461 W US 0007461W WO 0058264 A1 WO0058264 A1 WO 0058264A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
benzyl
carbon atoms
formula
synthesis
Prior art date
Application number
PCT/US2000/007461
Other languages
French (fr)
Inventor
Samuel I. Achilefu
Ananthachari Srinivasan
Original Assignee
Mallinckrodt Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc. filed Critical Mallinckrodt Inc.
Priority to AU37660/00A priority Critical patent/AU3766000A/en
Publication of WO2000058264A1 publication Critical patent/WO2000058264A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups

Definitions

  • This invention relates to the synthesis of esters of diethylenetriaminepentaacetic acid (DTPA) and of intermediates useful in the synthesis of such esters.
  • DTPA diethylenetriaminepentaacetic acid
  • R, and R 2 are H, and R 3 , R,,, and R 5 are t-butyl (compound (II)) or a similar protecting group.
  • Such compounds are useful in the preparation of nuclear pharmaceuticals where they serve as a metal chelate and a link between a peptide and a radionuclide.
  • Activation of the free dicarboxylic acid rapidly forms intramolecular acid anhydride which then reacts with the amino group on a peptide to form the DTPA-peptide conjugate.
  • Acid mediated cleavage of the esters gives free tetra-carboxylic acid which readily forms stable metal complexes with the radionuclide of choice.
  • Compound (IV) is commercially available.
  • Compound (III) was prepared by the method taught in Rapoport, J. Org. Chem. 1993, 58, 1 151-1 158 (incorporated herein by reference). This reaction yields two compounds in about a 1 :4 ratio.
  • the minor product is:
  • reaction product of (VI) and (VII) is:
  • This compound is subjected to catalytic hydrogenation at room temperature to yield
  • the invention comprises a method of synthesis of compounds of the formula
  • the invention comprises a method of synthesis of compounds of the formula
  • the invention includes a method for synthesizing compounds of the formula:
  • Rg and R 8 are linking moieties each having 1 to 10, desirably 1 to 6, preferably 1 to 4, and most preferably 2 carbon atoms; and each R 4 is an alkyl group having 1 to 15, desirably 2 to 10, more desirably 2 to 8, preferably 3 to 6, and more preferably 4 carbon atoms, and most preferably being t-butyl.
  • the compound When subjected to selective removal of the Rg group (for instance, by hydrogenation), the compound becomes:
  • R 8 is as defined above; both of R, are protecting groups that can be removed to leave a hydrogen, under conditions that do not remove any of R 4 , desirably benzyl, allyl, methoxybenzyl, nitrobenzyl, or chlortrityl, more preferably benzyl allyl, methoxybenzyl, or nitrobenzyl, preferably benzyl or allyl, and most preferably benzyl; and Z is a group that will react with the secondary amine of compound (XIV), desirably a halogen or a mesylate or a triflate, preferably Cl or Br, and most preferably Br; to produce:
  • This new procedure has several advantages over the prior art. Some of these include the use of fewer reaction steps, cheaper starting materials and high yield of the critical secondary amine (compound XIV). This method is also amenable to large-scale production and it is applicable to the production of a variety of DTPA derivatives.
  • the methylene chloride was removed with aspirator vacuum at ca. 35°C, and the remaining dimethylformamide was removed with vacuum at about 45°C.
  • the crude material was left on a vacuum line over night at room temperature.
  • the crude material from above was dissolved in 100 ml of methylene chloride at room temperature.
  • Triphenylphosphine (8.91 g, 34 mmol) was added and dissolved with stirring.
  • An argon purge was started and the mixture cooled to 0°C with an ice bath.
  • the N-bromosuccinimide (6.05 g, 34 mmol) was added portionwise over 2 minutes. The mixture was stirred for 1.5 hours at 0°C.
  • the methylene chloride was removed with vacuum and gave a purple oil.
  • This oil was triturated with 200 ml of ether with constant manual stirring. During this time the oil became very thick.
  • the ether solution was decanted and the oil was triturated with 100 ml of ether.
  • the ether solution was decanted and the oil was again triturated with a 100 ml portion of ether.
  • the ether was decanted and the combined ether solutions allowed to stand for about 2 hours to allow the triphenylphosphine oxide to crystallize.
  • the ether solution was decanted from the crystals and the solid washed with 100 ml of ether.
  • the volume of the combined ether abstracts was reduced with vacuum until a volume of about 25 ml was obtained. This was allowed to stand over night at 0°C.
  • Ether (10 ml) was added to the cold mixture which was mixed to suspend the solid.
  • the mixture was percolated through a column of 45 g of silica gel and eluted with ether, 75 ml fractions were collected.
  • the fractions that contained product by TLC were pooled and the ether removed with vacuum. This gave 10.1 g of crude product.
  • the material was flash chromatographed on silica gel with hexane, changing to 9: 1 hexane:ether.
  • the product-containing fractions were pooled and the solvents removed with vacuum. This gave 7.4 g (57% yield) of pure product.
  • N- benzyl-N,N'N'-tris(t-butyloxycarbonylmethyl) ethylenediamine (from Example 2) (6 g, 12 mmol) was added to a heterogeneous mixture of 10% palladium on carbon (6 g, 1 weight equivalent) in 100 ml of methanol.
  • Anhydrous ammonium formate (3.8 g, 60.26 mmol) was added to the reaction mixture in one bulk. The mixture was stirred at room temperature for 2 hours.
  • DTPA-Octreotate derivative Synthesis of DTPA-Octreotate derivative.
  • the DTPA-Octreotate conjugate was prepared by solid phase synthesis using pre-loaded fluorenemethoxycarbonyl- threonine (Fmoc-Thr) Wang resin on 0.025 mmol scale.
  • Commercially available automated peptide synthesizer from Applied Biosystems Model 432A SYNERGY Peptide Synthesizer
  • Cartridges containing Fmoc-protected amino acids were used in the solid phase synthesis. Cysteines were protected with acetamidomethyl group.
  • Coupling reaction was carried out with 0.075 mmol of the protected amino acid and 2-(lH-benzotriazole-lyl)-l,l,3,3-tetramethyluronium hexafluorophosphate (HBTU)/N-hydroxybenzotriazole (HOBT).
  • the amino acids and tri-t-butyl DTPA (compound II) cartridges were placed on the peptide synthesizer and the product was synthesized from the C-terminal to the N-terminal position. After the synthesis was completed, the product was cleaved from the solid support with a cleavage mixture containing trifluoroacetic acid (85%):water (5%):phenol (5%):thioanisole (5%) for 6 hours.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The synthesis of compounds of formula (XIV) wherein each R4 is an alkyl group having 1 to 15 carbon atoms, and R6 is a linking moiety having 1 to 10 carbon atoms, is disclosed. These compounds are useful intermediates in the synthesis of compounds of formula (X). These compounds are useful in the preparation of nuclear pharmaceuticals such as those used for tumor imaging or tumor therapy.

Description

METHOD FOR THE SYNTHESIS OF NON-SYMMETRICAL DTPA COMPOUNDS
BACKGROUND OF THE INVENTION
This invention relates to the synthesis of esters of diethylenetriaminepentaacetic acid (DTPA) and of intermediates useful in the synthesis of such esters. These esters have the general formula:
Figure imgf000003_0001
(I)
wherein R, and R2 are H, and R3, R,,, and R5 are t-butyl (compound (II)) or a similar protecting group. Such compounds are useful in the preparation of nuclear pharmaceuticals where they serve as a metal chelate and a link between a peptide and a radionuclide. Activation of the free dicarboxylic acid rapidly forms intramolecular acid anhydride which then reacts with the amino group on a peptide to form the DTPA-peptide conjugate. Acid mediated cleavage of the esters gives free tetra-carboxylic acid which readily forms stable metal complexes with the radionuclide of choice.
Using conventional techniques, these compounds are prepared by the following sequence (t-Bu = t-butyl):
Figure imgf000003_0002
(III) (IV)
Compound (IV) is commercially available. Compound (III) was prepared by the method taught in Rapoport, J. Org. Chem. 1993, 58, 1 151-1 158 (incorporated herein by reference). This reaction yields two compounds in about a 1 :4 ratio. The major product is the penta ester (compound (V)), (i.e.: compound (I) in which all of RrR5 = t-butyl). This product is useless and must be disposed of. The minor product is:
Figure imgf000004_0001
(VI)
Compound (VI) is reacted with the compound (Bz = benzyl):
Figure imgf000004_0002
(VII)
This compound is not commercially available, but may be synthesized by literature method as described by Rapoport (see the reference for compound (III) above).
The reaction product of (VI) and (VII) is:
Figure imgf000004_0003
(vπi)
This compound is subjected to catalytic hydrogenation at room temperature to yield
Figure imgf000005_0001
(II) (i.e.: compound (I) where R and R2 are H and R3, R4, and R5 are t-butyl).
The synthesis described above suffers from several problems, the primary being that the major product of the first reaction is a waste product that must be disposed of. Another problem is that exhaustive chromatographic purification is required to isolate the minor product. This process further lowers the final yield of compound (VI) as a result of the inherent instability of compound (VI) on silica gel columns. The conventional method requires the preparation of several reaction intermediates which is time-consuming and may not be amenable to large-scale production.
Accordingly it would be desirable to have an alternative synthesis of these compounds.
US 5,618,513 (Mallinckrodt: A. Srinivasan) teaches a general method for using DTPA compounds in the preparation of radiopharmaceuticals. This reference also teaches the preparation of such compounds as outlined above.
US 4,479,930 (Univ. of Massachusetts: D. Hnatowich) teaches the use of a dicyclic dianhydride compound to couple polypeptides. Although useful, this method results in diaddition products which are not medically useful.
S. Ram and L. Spicer, Rapid Debenzylation of N-Benzylamino Derivatives to Amino-Derivatives Using Ammonium Formate as Catalytic Hydrogen Transfer
Agent, Tetrahedron Letters, Vol. 28, No. 5, pp 515-516, 1987, teaches the deprotection of various N-benzyl compounds using ammonium formate as the hydrogen source.
S. Ram and L. Spicer, Debenzylation of N-Benzylamino Derivatives by Catalytic Transfer Hydrogenation with Ammonium Formate, Synthetic Communication, 17(4), 415-418 (1987), is similar to the first Ram and Spicer reference.
C. Grote, D. Kim, and H. Rapoport, Stereocontrolled Synthesis of DTPA Analogues Branched in the Ethylene Unit, J. Org. Chem., 1995, 60, 6987-6997, teaches a synthesis similar to that outlined above, with the addition of stereo control of the reaction.
M. Brechbiel and O. Gansow, Backbone-Substituted DTPA Ligands for 90Y Radioimmunotherapy, Bioconjugate Chem. 1991, -2, 187-194, teaches the synthesis of new bifunctional DTPA ligands.
SUMMARY OF THE INVENTION
Briefly, the invention comprises a method of synthesis of compounds of the formula
Figure imgf000006_0001
(XIV)
In another respect the invention comprises a method of synthesis of compounds of the formula
Figure imgf000006_0002
(X) DETAILED DESCRIPTION OF THE INVENTION
In this specification and claims, numerical values and ranges are not critical unless otherwise stated. That is, the numerical values and ranges may be read as if they were prefaced with the word "about" or "substantially".
The invention includes a method for synthesizing compounds of the formula:
Figure imgf000007_0001
(X) wherein Rg and R8 are linking moieties each having 1 to 10, desirably 1 to 6, preferably 1 to 4, and most preferably 2 carbon atoms; and each R4 is an alkyl group having 1 to 15, desirably 2 to 10, more desirably 2 to 8, preferably 3 to 6, and more preferably 4 carbon atoms, and most preferably being t-butyl.
The synthesis begins with the reaction of: H2N R6 NH τ X' "COOR4 κ9
(XI) (XII) wherein R4, R^, are as defined above; W^ is a removable protecting group, desirably benzyl, trifluoroacetyl, methoxy benzyl, chlorotrityl, or nitrobenzyl, preferably benzyl, trifluoroacetyl, or methoxy benzyl, and most preferably benzyl; and X is a group that will react with the amines of compound (XI), desirably a halogen or a mesylate or a triflate, more desirably a halogen, preferably Cl or Br, and most preferably Br. This reaction produces:
Figure imgf000007_0002
(XIII)
When subjected to selective removal of the Rg group (for instance, by hydrogenation), the compound becomes:
Figure imgf000008_0001
(XIV)
Compound (XIV) is known from the conventional synthesis described in the
Background of the Invention, above. However, in this reaction it is produced as essentially the sole product, rather than as the minor product. From this point on, the synthesis is conventional. Compound (XIV) can be reacted with:
Figure imgf000008_0002
(XV) wherein R8 is as defined above; both of R, are protecting groups that can be removed to leave a hydrogen, under conditions that do not remove any of R4, desirably benzyl, allyl, methoxybenzyl, nitrobenzyl, or chlortrityl, more preferably benzyl allyl, methoxybenzyl, or nitrobenzyl, preferably benzyl or allyl, and most preferably benzyl; and Z is a group that will react with the secondary amine of compound (XIV), desirably a halogen or a mesylate or a triflate, preferably Cl or Br, and most preferably Br; to produce:
Figure imgf000008_0003
(XVI) This compound can then be subjected to hydrogenation to replace both R{ moieties with hydrogens, to yield compound (X).
This new procedure has several advantages over the prior art. Some of these include the use of fewer reaction steps, cheaper starting materials and high yield of the critical secondary amine (compound XIV). This method is also amenable to large-scale production and it is applicable to the production of a variety of DTPA derivatives.
EXAMPLE 1
Synthesis of 2-[Bis-(benzyloxycarbonylmethyl)amino]ethyl bromide (Compound (VII) or Compound (XV) where Z = Br, R8 = ethyl, and Rj = benzyl). A solution of 50 ml of dimethylformamide and benzyl bromoacetate (16.0 g, 70 mmol) was stirred in a 100 ml three-neck flask. Solid potassium bicarbonate (7.8 g, 78 mmol) was added. The flask was purged with argon and cooled to 0°C with an ice bath. To the stirring mixture was added dropwise a solution of ethanolamine (1.9 g, 31 mmol) and 4 ml of dimethylformamide over 5 minutes. After the addition was complete the mixture was stirred for 1 hour at 0°C. The ice bath was removed and the mixture stirred at room temperature over night. The reaction mixture was partitioned between 100 ml of methylene chloride and 100 ml of saturated sodium bicarbonate solution. The layers were separated and the methylene chloride layer was again washed with 100 ml of saturated sodium bicarbonate solution. The combined aqueous layers were extracted twice with 25 ml of methylene chloride. The combined methylene chloride layers were washed with 100 ml of brine, and dried over magnesium sulfate. The methylene chloride was removed with aspirator vacuum at ca. 35°C, and the remaining dimethylformamide was removed with vacuum at about 45°C. The crude material was left on a vacuum line over night at room temperature. The crude material from above was dissolved in 100 ml of methylene chloride at room temperature. Triphenylphosphine (8.91 g, 34 mmol) was added and dissolved with stirring. An argon purge was started and the mixture cooled to 0°C with an ice bath. The N-bromosuccinimide (6.05 g, 34 mmol) was added portionwise over 2 minutes. The mixture was stirred for 1.5 hours at 0°C. The methylene chloride was removed with vacuum and gave a purple oil. This oil was triturated with 200 ml of ether with constant manual stirring. During this time the oil became very thick. The ether solution was decanted and the oil was triturated with 100 ml of ether. The ether solution was decanted and the oil was again triturated with a 100 ml portion of ether. The ether was decanted and the combined ether solutions allowed to stand for about 2 hours to allow the triphenylphosphine oxide to crystallize. The ether solution was decanted from the crystals and the solid washed with 100 ml of ether. The volume of the combined ether abstracts was reduced with vacuum until a volume of about 25 ml was obtained. This was allowed to stand over night at 0°C. Ether (10 ml) was added to the cold mixture which was mixed to suspend the solid. The mixture was percolated through a column of 45 g of silica gel and eluted with ether, 75 ml fractions were collected. The fractions that contained product by TLC were pooled and the ether removed with vacuum. This gave 10.1 g of crude product. The material was flash chromatographed on silica gel with hexane, changing to 9: 1 hexane:ether. The product-containing fractions were pooled and the solvents removed with vacuum. This gave 7.4 g (57% yield) of pure product.
EXAMPLE 2 Synthesis of N-benzyl-N,N',N'-tris(t-butyloxycarbonylmethyl) ethylenediamine (Compound (XIII) where R4 = t-butyl, R^ = ethyl, and R, = benzyl). N-Benzylethylenediamine (Compound (XI) where R^ = ethyl and Rg = benzyl) (5g, 33.28 mmol) and potassium bicarbonate (19.3g, 139.7 mmol) were added to 200 ml of anhydrous acetonitrile and stirred vigorously under argon, t- Butyl bromoacetate (Compound (XII) where X = Br and R4 = t-butyl) was diluted in 30 ml of anhydrous acetonitrile and the solution was added dropwise to the reaction mixture over 90 minutes. The progress of the reaction was monitored by thin-layer chromatography and was essentially complete in about 4 hours but was stirred at room temperature for about 12 hours in order to assure complete alkylation of the amine. The insoluble residue was filtered and washed with acetonitrile. The filtrate was evaporated to give 20g of a yellow liquid. Hexane (100 ml) was added to the crude mixture and stirred vigorously until white precipitate formed. The precipitate was filtered and the filtrate was evaporated to give a yellow liquid. The pure compound was obtained by washing the crude product over dry flash chromatographic column and the desired compound was eluted with 10% diethyl ether in hexane (12.5 g, 80% yield).
EXAMPLE 3
Synthesis of N,N',N'-tris(t-butyloxycarbonylmethyI)ethylenediamine (Compound (VI) or Compound (XIV) where R4 = t-butyl and Rg = ethyl). N- benzyl-N,N'N'-tris(t-butyloxycarbonylmethyl) ethylenediamine (from Example 2) (6 g, 12 mmol) was added to a heterogeneous mixture of 10% palladium on carbon (6 g, 1 weight equivalent) in 100 ml of methanol. Anhydrous ammonium formate (3.8 g, 60.26 mmol) was added to the reaction mixture in one bulk. The mixture was stirred at room temperature for 2 hours. The mixture was filtered over celite and the residue was washed with chloroform. The filtrate was evaporated until white precipitates began to form. The residue was triturated in chloroform and the insoluble formate was filtered. Evaporation of the filtrate gave a pale yellow liquid (4.6 g, 96% yield) which was identified as the pure compound by NMR analysis.
EXAMPLE 4
Synthesis of N,N',N'-tris(t-butyloxycarbonylmethyl)-N",N"- bis(benzyloxycarbonylmethyl)diethylenetriamine (Compound (VIII) or
Compound (XVI) where Rj = benzyl, R4 = t-butyl, and R6 = ethyl). A mixture of N,N'N'-tris(t-butyloxycarbonylmethyl) ethylenediamine (4.4 g, 9.82 mmol) and 2-[Bis-(benzyloxycarbonylmethyl)amino]ethyl bromide (5.3 g, 12.76 mmol) was added to a solution of ethydiisopropylamine (3.8 g, 29.45 mmol) in 100 ml acetonitrile. The mixture was stirred at reflux for 24 hours under nitrogen. After the reaction was complete, the solvent was evaporated and the residue was partitioned between dichloromethane (100 ml) and distilled water (100 ml). The organic layer was washed with 100 ml of water and 100 ml of brine. It was dried over magnesium sulfate and the solvent was evaporated to give about 10 g of the crude product. The product was purified by dry flash chromatography and the pure compound was eluted with 40% of diethyl ether in hexane as a pale yellow liquid (6.5 g, 90% yield).
EXAMPLE 5
Preparation of N,N',N'-tris(t-butyloxycarbonylmethyl)-N",N"-bis(acetic acid)diethylenetriamine (II). A mixture of 10% palladium on carbon (0.21 g) and a solution of N,N',N'-tris(t-butyloxycarbonylmethyl)-N",N"- bis(benzyloxycarbonylmethyl)diethylenetriamine (3.3 g, 4.45 mmol) in 50 ml of methanol was hydrogenolyzed at 40 psi for 2 hours. The mixture was filtered over celite and the residue was washed with methanol. The solvent was evaporated to give an off-white powder which was shown by mass spectral analysis, HPLC and NMR to be the pure compound (2.4 g, 96% yield).
EXAMPLE 6
Synthesis of DTPA-Octreotate derivative. The DTPA-Octreotate conjugate was prepared by solid phase synthesis using pre-loaded fluorenemethoxycarbonyl- threonine (Fmoc-Thr) Wang resin on 0.025 mmol scale. Commercially available automated peptide synthesizer from Applied Biosystems (Model 432A SYNERGY Peptide Synthesizer) was used. Cartridges containing Fmoc-protected amino acids were used in the solid phase synthesis. Cysteines were protected with acetamidomethyl group. Coupling reaction was carried out with 0.075 mmol of the protected amino acid and 2-(lH-benzotriazole-lyl)-l,l,3,3-tetramethyluronium hexafluorophosphate (HBTU)/N-hydroxybenzotriazole (HOBT). The amino acids and tri-t-butyl DTPA (compound II) cartridges were placed on the peptide synthesizer and the product was synthesized from the C-terminal to the N-terminal position. After the synthesis was completed, the product was cleaved from the solid support with a cleavage mixture containing trifluoroacetic acid (85%):water (5%):phenol (5%):thioanisole (5%) for 6 hours. Note that the t-butyl esters of tri-t- butyl DTPA were also cleaved to give the free tetra-carboxylic acid. The DTPA- peptide conjugate was precipitated with t-butyl methyl ether and lyophilized with water : acetonitrile (2/3) mixture. Mass spectral analysis indicated that only the mono peptide-DTPA conjugate was obtained in accordance with the following sequence: DTP A-D-Phe-Cys(Acm)-Tyr-D-T -Lys-The-Cys(Acm)-Thr.
-π-

Claims

What is claimed is:
1. A method of synthesizing a compound of the formula:
Figure imgf000014_0001
(XIV) wherein each R4 is an alkyl group having 1 to 15 carbon atoms, and R^ is a linking moiety having 1 to 10 carbon atoms, comprising
(a) reacting together compounds of the formulas:
H2N R6 NH + X COOR4 R9
(XI) (XII) wherein R^ and Rg, are as defined above, R9 is a removable protecting group, and X is a group that will react with the amines of compound (XI), to produce a compound of the formula:
Figure imgf000014_0002
(XIII) and;
(b) selectively removing Re, to produce compound (XIV).
2. The method of claim 1 wherein each R4 has 2 to 8 carbon atoms, R has 1 to 6 carbon atoms, R9 is benzyl, trifluoroacetyl, methoxy benzyl, chlorotrityl, or nitrobenzyl, and X is a halogen, a mesylate, or a triflate.
3. The method of claim 2 wherein each R4 has 3 to 6 carbon atoms, R^ has 1 to 4 carbon atoms, Re, is benzyl, trifluoroacetyl, or methoxy benzyl, and X is a halogen.
4. The method of claim 3 wherein each R4 is t-butyl, Rg is ethyl, Rg is benzyl, and X is Br.
5. A method of preparing a compound of the formula
Figure imgf000015_0001
(X) wherein each R4 is an alkyl group having 1 to 15 carbon atoms, and Rg and R8 are each linking moieties having 1 to 10 carbon atoms, comprising (a) reacting together compounds of the formulas:
H2N R6 NH
\ + X' "COOR4
R9
(XI) (XII) wherein R^ and Rg, are as defined above, Rς, is a removable protecting group, and X is a group that will react with the amines of compound (XI), to produce a compound of the formula:
Figure imgf000015_0002
(XIII);
(b) selectively removing Rg to produce a compound of the formula:
Figure imgf000015_0003
(XIV);
(c) reacting compound (XIV) with a compound of the formula:
Figure imgf000016_0001
(XV) wherein R8 is as defined above; both of R{ are protecting groups that can be removed to leave a hydrogen, under conditions that do not remove any of R4; and Z is a group that will react with the secondary amine of compound (XIV), to produce a compound of the formula:
Figure imgf000016_0002
(XVI) and; (d) selectively replacing both R moieties with hydrogens, to yield compound
(X).
6. The method of claim 5 wherein R, is benzyl, allyl, methoxybenzyl, nitrobenzyl, or chlortrityl,, each R4 has 2 to 8 carbon atoms, R$ and R8 each have 1 to 6 carbon atoms, Rg is benzyl, trifluoroacetyl, methoxy benzyl, chlorotrityl, or nitrobenzyl, and X is a halogen, a mesylate, or a triflate.
7. The method of claim 6 wherein R, is benzyl, or allyl, each R4 has 3 to 6 carbon atoms, R-g and R8 each have 1 to 4 carbon atoms, R^ is benzyl, trifluoroacetyl, or methoxy benzyl, and X is a halogen.
8. The method of claim 7 wherein R, is benzyl, each R4 is t-butyl, Rg and R8 are each ethyl, Rg is benzyl, and X is Br.
9. The method of claim 5 wherein Rj is an alkyl group having 2 to 8 carbon atoms and R4 is benzyl, trifluoroacetyl, methoxy benzyl, chlorotrityl, or nitrobenzyl.
10. The method of claim 5 wherein R] is t-butyl and R4 is benzyl.
PCT/US2000/007461 1999-03-26 2000-03-21 Method for the synthesis of non-symmetrical dtpa compounds WO2000058264A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU37660/00A AU3766000A (en) 1999-03-26 2000-03-21 Method for the synthesis of non-symmetrical dtpa compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12648299P 1999-03-26 1999-03-26
US60/126,482 1999-03-26

Publications (1)

Publication Number Publication Date
WO2000058264A1 true WO2000058264A1 (en) 2000-10-05

Family

ID=22425068

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/007461 WO2000058264A1 (en) 1999-03-26 2000-03-21 Method for the synthesis of non-symmetrical dtpa compounds

Country Status (2)

Country Link
AU (1) AU3766000A (en)
WO (1) WO2000058264A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601060A1 (en) * 1996-01-04 1997-07-10 Schering Ag New monofunctionalized EDTA, DTPA and TTHA derivatives and their use in medical diagnostics and therapy
US5736120A (en) * 1996-06-07 1998-04-07 Srinivasan; Ananthachari Method for preparing radiolabeled peptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601060A1 (en) * 1996-01-04 1997-07-10 Schering Ag New monofunctionalized EDTA, DTPA and TTHA derivatives and their use in medical diagnostics and therapy
US5736120A (en) * 1996-06-07 1998-04-07 Srinivasan; Ananthachari Method for preparing radiolabeled peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
S. ACHILEFU ET AL.: "A NEW METHOD FOR THE SYNTHESIS OF TRI-TERT.-BUTYL DIETHYLENTRIAMINEPENTAACETIC ACID AND IT'S DERIVATIVES", JOURNAL OF ORGANIC CHEMISTRY, vol. 65, no. 5, 2000, pages 1562 - 1565, XP002140823 *

Also Published As

Publication number Publication date
AU3766000A (en) 2000-10-16

Similar Documents

Publication Publication Date Title
NZ229281A (en) Diol-containing renin inhibitors
KR960014355B1 (en) New macrocyclic nigaands
US4562263A (en) Process for producing 3-(3,4-dihydroxyphenyl) serine
EP2415744A1 (en) Fluorene compound
JPH03176495A (en) Dopamine and preparation of 4-o-phosphoric acid ester derived from said dopamine
PL125548B1 (en) Process for preparing novel derivatives of acylated homotaurine
US5264577A (en) Cyclic amino acids and derivatives thereof
KR20040108717A (en) Method for preparing combretastatins
CA2546506C (en) Method for synthesis of perindopril and the pharmaceutically-acceptable salts thereof
JPH0479349B2 (en)
US5117009A (en) Xanthenylamide handle for use in peptide synthesis
JPH02306947A (en) Preparation of chiral bata-amino acid
JP3163391B2 (en) Stilbene derivatives and anticancer agents containing the same
WO2000058264A1 (en) Method for the synthesis of non-symmetrical dtpa compounds
RU2182908C2 (en) Stereoisomeric indole compounds, method of their synthesis and their using
EP0769003B1 (en) Amino acid-derived diaminopropanols
WO2000058269A1 (en) Dtpa esters with orthogonal removable protecting groups
JPH0346460B2 (en)
WO2000058266A1 (en) Divergent method for the synthesis of diethylene triaminepenta aceticacid esters
JP2001521498A (en) Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide
US5346995A (en) Preparation of copper 2-alkoxyisobutylisonitrile complexes and 99m Tc labelling of 2-alkoxyisobutylisonitrile
Doerge et al. Synthesis of N-substituted benzimidazole-2-thiones
KR100708581B1 (en) A process for the synthesis of ritonavir
Gros et al. Stereochemical control in the preparation of α-amino N-methylthiazolidine masked aldehydes used for peptide aldehydes synthesis
EP0365412B1 (en) Cyclic nitrogen-containing ligands, their metal complexes, diagnostic compositions containing these complexes and method of preparing the ligands

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase